{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260505524502/en/Sensei-Biotherapeutics-Doses-First-Patient-in-Phase-1b2-Trial-of-PIKTOR-in-HRHER2--Advanced-Breast-Cancer", "message": "News view counter 702995 successfully enlarged"}